Home > Financial Ratios > MOREPEN LABORATORIES

MOREPEN LABORATORIES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for MOREPEN LABORATORIES
Please provide your vote to see the results

MOREPEN LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 11.49101.47-45.3620.0567.42

What is the latest Core EBITDA Growth ratio of MOREPEN LABORATORIES ?

The latest Core EBITDA Growth ratio of MOREPEN LABORATORIES is 11.49 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202511.49
Mar2024101.47
Mar2023-45.36
Mar202220.05
Mar202167.42

How is Core EBITDA Growth of MOREPEN LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 11.49
-88.68
Mar2024 101.47
Positive
Mar2023 -45.36
Negative
Mar2022 20.05
-70.26
Mar2021 67.42 -

Other Financial Ratios of MOREPEN LABORATORIES


Compare Core EBITDA Growth ratio of peers of MOREPEN LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MOREPEN LABORATORIES ₹1,949.8 Cr -7.7% -8.2% -44.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,773.0 Cr -6.8% -7.6% -4.7% Stock Analytics
DIVIS LABORATORIES ₹159,540.0 Cr -6.6% -5.8% 4.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,529.0 Cr 0.9% 5.7% 27.3% Stock Analytics
CIPLA ₹111,299.0 Cr -4.8% -8.1% -3.9% Stock Analytics
DR REDDYS LABORATORIES ₹97,393.0 Cr -2% -8.8% -12.9% Stock Analytics


MOREPEN LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MOREPEN LABORATORIES

-7.7%

-8.2%

-44.7%

SENSEX

-2%

-2.8%

7.4%


You may also like the below Video Courses